<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T18:00:12Z</responseDate>
  <request identifier="oai:figshare.com:article/34047820" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047820</identifier>
        <datestamp>2026-10-01T17:27:41Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Meta-regression results.&lt;/p&gt;</dc:title>
          <dc:creator>Tom C. Gordon (22177071)</dc:creator>
          <dc:creator>Andrew H. Kemp (8382396)</dc:creator>
          <dc:creator>Josh Hope-Bell (18530333)</dc:creator>
          <dc:creator>Darren J. Edwards (15205651)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>observed across healthy</dc:subject>
          <dc:subject>randomised controlled trials</dc:subject>
          <dc:subject>psychological flexibility (&lt;</dc:subject>
          <dc:subject>g ., act</dc:subject>
          <dc:subject>predicted larger short</dc:subject>
          <dc:subject>mental health outcomes</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>moderate immediate post</dc:subject>
          <dc:subject>46 ), quality</dc:subject>
          <dc:subject>immediate post</dc:subject>
          <dc:subject>substantial across</dc:subject>
          <dc:subject>61 trials</dc:subject>
          <dc:subject>491 ),</dc:subject>
          <dc:subject>46 trials</dc:subject>
          <dc:subject>41 trials</dc:subject>
          <dc:subject>30 ),</dc:subject>
          <dc:subject>130 ),</dc:subject>
          <dc:subject>outcomes (&lt;</dc:subject>
          <dc:subject>interventions (&lt;</dc:subject>
          <dc:subject>g &lt;/</dc:subject>
          <dc:subject>yielded small</dc:subject>
          <dc:subject>whether changes</dc:subject>
          <dc:subject>wave process</dc:subject>
          <dc:subject>wave interventions</dc:subject>
          <dc:subject>term follow</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>qm &lt;/</dc:subject>
          <dc:subject>process outcomes</dc:subject>
          <dc:subject>population type</dc:subject>
          <dc:subject>p &lt;/</dc:subject>
          <dc:subject>n &lt;/</dc:subject>
          <dc:subject>medical samples</dc:subject>
          <dc:subject>longer follow</dc:subject>
          <dc:subject>k &lt;/</dc:subject>
          <dc:subject>january 2026</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;To synthesise the efficacy of digital third-wave process-based interventions (e.g., ACT, Mindfulness, Compassion) for improving wellbeing and ameliorating mental health symptoms in adults. A prospectively registered systematic review (OSF: &lt;a href="https://doi.org/10.17605/OSF.IO/5RMU2" target="_blank"&gt;10.17605/OSF.IO/5RMU2&lt;/a&gt;) and random-effects meta-analysis of randomised controlled trials (RCTs) was conducted across six databases through January 2026. Certainty of evidence was assessed using the GRADE framework. Interventions (&lt;i&gt;k&lt;/i&gt; = 147; &lt;i&gt;N&lt;/i&gt; = 26,391) yielded small-to-moderate immediate post-intervention improvements in wellbeing (&lt;i&gt;k&lt;/i&gt; = 46, &lt;i&gt;g&lt;/i&gt; = 0.36), depression (&lt;i&gt;k&lt;/i&gt; = 110, &lt;i&gt;g&lt;/i&gt; = 0.44), anxiety (&lt;i&gt;k&lt;/i&gt; = 93, &lt;i&gt;g&lt;/i&gt; = 0.40), stress (&lt;i&gt;k&lt;/i&gt; = 66, &lt;i&gt;g&lt;/i&gt; = 0.46), quality of life (&lt;i&gt;k&lt;/i&gt; = 32, &lt;i&gt;g&lt;/i&gt; = 0.30), and psychological flexibility (&lt;i&gt;k&lt;/i&gt; = 51, &lt;i&gt;g&lt;/i&gt; = 0.41). Heterogeneity was substantial across most outcomes (&lt;i&gt;I2&lt;/i&gt; &gt; 75%). Benefits were observed across healthy (61 trials; &lt;i&gt;n&lt;/i&gt; = 15,770), mental health (41 trials; &lt;i&gt;n&lt;/i&gt; = 6,130), and medical samples (46 trials; &lt;i&gt;n&lt;/i&gt; = 4,491), with population type not significantly moderating immediate post-intervention effects. Comparator type significantly moderated several analyses, with smaller effects against active than inactive controls. Guidance did not significantly moderate immediate post-intervention effects, although it predicted larger short-term depression effects (&lt;i&gt;QM&lt;/i&gt; = 4.17, &lt;i&gt;p&lt;/i&gt; = .048). At short-term follow-up, effects remained statistically supported across all outcomes, while only depression, anxiety, and stress remained statistically supported at medium-term follow-up. GRADE certainty was moderate for most immediate post-intervention outcomes and low for quality of life. Digital third-wave interventions produced small-to-moderate average benefits across symptom-focused, wellbeing-focused, and process outcomes. Effects were smaller against active comparators, indicating that pooled benefits should be interpreted in relation to comparator intensity. Future research should prioritise rigorous active controls, longer follow-up, and direct tests of whether changes in psychological flexibility mediate improvements in symptoms and wellbeing.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-10-01T17:27:31Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1371/journal.pdig.0001764.s008</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/_p_Meta-regression_results_p_/34047820</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
